Wei Qi
Tianjin University(CN)Chinese Academy of Sciences(CN)Chinese Academy of Sciences(CN)ShanghaiTech University(CN)Wuhan University(CN)Institute of Microelectronics(CN)Beijing Aerospace General Hospital(CN)Guangzhou Institute of Energy Conversion(CN)Renmin Hospital of Wuhan University(CN)Tianjin Chest Hospital(CN)Hongzhiwei Technology (China)(CN)Shanghai Clinical Research Center(CN)University of Chinese Academy of Sciences(CN)
Publications by Year
Research Areas
Epigenetics and DNA Methylation, Cholesterol and Lipid Metabolism, Cancer-related gene regulation, RNA modifications and cancer, Genomics and Chromatin Dynamics
Most-Cited Works
- → Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation(2012)543 cited
- → Inhibition of SREBP by a Small Molecule, Betulin, Improves Hyperlipidemia and Insulin Resistance and Reduces Atherosclerotic Plaques(2011)405 cited
- → Cholesterol Transport through Lysosome-Peroxisome Membrane Contacts(2015)375 cited
- → The Cholesterol Absorption Inhibitor Ezetimibe Acts by Blocking the Sterol-Induced Internalization of NPC1L1(2008)372 cited
- → PP2A Is Required for Centromeric Localization of Sgo1 and Proper Chromosome Segregation(2006)323 cited
- → An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED(2017)316 cited